Krsnaa Diagnostics releases Q4FY26 earnings call recording
Krsnaa Diagnostics Limited has disclosed the audio recording link for its earnings conference call regarding the quarter and year ended March 31, 2026. The call was conducted on May 26, 2026, and included participation from senior management including the Chairman, Managing Director, and Group CEO. The recording is now available for shareholders on the company's official website.

*this image is generated using AI for illustrative purposes only.
Krsnaa Diagnostics Limited has made the audio recording of its post-earnings conference call available for stakeholders. The call, conducted to discuss financial results for the quarter and year ended March 31, 2026, was held on Tuesday, May 26, 2026, at 12:30 Hrs. (IST). The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The conference call featured a presentation by the company's management regarding the financial performance for the specified periods, followed by an interactive question-and-answer session. Key participants included Mr. Rajendra Mutha (Chairman & Whole-time Director), Mr. Yash Mutha (Managing Director), Mr. Mitesh Dave (Group CEO), Mr. Chandra Prakash Singh (Interim CFO), and Mr. Sujoy Bose (Head- Secretarial, Legal and Compliance).
Access to Recordings
The audio recording of the earnings call is now available on the official website of Krsnaa Diagnostics Limited. Stakeholders can access the recording via the specific link provided in the investors section.
| Resource | Availability |
|---|---|
| Earnings Call Recording | Available on company website |
The original access numbers for domestic and international participants are no longer required as the event has concluded. The company has confirmed that the recording link is now live for public access.
Historical Stock Returns for Krsnaa Diagnostics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.88% | -2.81% | -8.67% | -31.90% | -14.67% | -44.38% |
What strategic initiatives did management highlight during the Q&A session to drive growth in FY2027?
How does Krsnaa Diagnostics plan to navigate potential regulatory changes impacting the diagnostic sector?
What are the expected capital expenditure plans for the upcoming fiscal year based on the earnings discussion?


































